Home›Stock Screener›Onyx Biotec›Financial Statements

Onyx Biotec Complete Financial Statements

5 Years of Data
2026 - 2022

In FYNone, Onyx Biotec (ONYX) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of -1.4% and ROE of -1.8%. Full financial statements from FY2022 to FY2026 (5 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse Onyx Biotec shareholding analysis to track promoter, FII and institutional holdings.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin -1.45% 2026 data
EBITDA Margin 4.35% 2026 data
Operating Margin 5.00% 2026 data
Return on Assets -1.05% 2026 data
Return on Equity -1.82% 2026 data

Balance Sheet Ratios

Current Ratio 7.29 2026 data
Equity Ratio 57.89% 2026 data
Asset Turnover 0.73 2026 data

ONYX Revenue, Net Profit & EBITDA — Year-on-Year Growth

ONYX YoY (March 2026 vs Period) — revenue -100.0%, net profit +100.0%, EBITDA -100.0%, expenses -100.0%. Also explore ONYX price trends to track price trends across different timeframes.

Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
+100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+4.4%
Year-over-Year
Equity Growth
-1.8%
Year-over-Year
Operating Cash Flow Growth
-50.0%
Year-over-Year
Investing Cash Flow Growth
+133.3%
Year-over-Year
Financing Cash Flow Growth
+66.7%
Year-over-Year

ONYX Income Statement — Revenue, EBITDA & Net Profit

Onyx Biotec revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin -1.4%. For live price, earnings ratios and company overview, see Onyx Biotec screener.

Periods ₹ Crores
Particulars None March 2026 March 2025 March 2024 March 2023 March 2022
Revenue 0 69 63 54 40 45
Expenses 0 66 52 45 35 39
EBITDA 0 3 12 9 5 6
Operating Profit Margin % 0.00% 5.00% 17.00% 16.00% 11.00% 13.00%
Depreciation 0 3 3 2 2 1
Interest 0 1 2 2 1 1
Profit Before Tax 0 0 7 5 3 4
Tax 0 0 2 1 1 0
Net Profit 0 -1 5 4 2 3
Earnings Per Share (₹) 0.00 -0.12 3.31 3.05 1.56 2.84

ONYX Balance Sheet — Assets, Liabilities & Shareholders' Equity

ONYX total assets ₹95 Cr, total equity ₹55 Cr, total liabilities ₹ Cr (2026) — ROE -1.8%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022
ASSETS
Total Assets 95 91 74 59 37
Current Assets 51 49 30 15 14
Fixed Assets 43 41 44 43 17
Capital Work in Progress 4 0 0 0 4
Investments 14 0 0 0 0
Other Assets 0 50 31 16 16
LIABILITIES
Total Liabilities
Current Liabilities 7 10 26 20 10
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 55 56 25 18 16
Share Capital 18 18 13 6 6
Reserves & Surplus 37 38 12 12 11

ONYX Cash Flow Statement — Operating, Investing & Financing

Onyx Biotec operating cash flow ₹1 Cr, investing ₹1 Cr, financing ₹5 Cr, net cash flow ₹7 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022
Operating Activities 1 2 2 1
Investing Activities 1 -3 -23 -6
Financing Activities 5 3 16 5
Net Cash Flow 7 2 -4 0